-
公开(公告)号:US20220133671A1
公开(公告)日:2022-05-05
申请号:US17430287
申请日:2020-02-10
IPC分类号: A61K31/215 , A61P35/00 , A61K31/351 , A61K31/401 , A61K31/4406 , A61K31/4402 , A61K31/4422 , A61K31/445 , A61K31/455 , A61K31/55 , A61K31/60
摘要: The present disclosure relates to methods of preventing or inhibiting fibrosis using small molecule sialidase inhibitors. The present disclosure also relates to methods treating obesity, liver inflammation, steatosis, and cancer. These methods can involve administering the compounds to a patent at risk of developing fibrosis inflammation, obesity, steatosis, or cancer, in a manner that inhibits NEU3.